Marketresearchnews

Friday, 6 September 2019

Lactose Intolerance Treatment Market - Granular Market Report and Review, 2019

Market scenario:

Lactose intolerance cause symptoms such as abdominal pain, bloating, diarrhoea, gas, nausea etc. due to the decreased ability to digest the sugar lactose in milk products. Lactose intolerance is caused due to the lack of enzyme lactase which breaks lactose into glucose and galactose. Primary lactose intolerance is due to fall in the amount of lactase due to age while secondary lactose intolerance is due to injury to the small intestine such as infections, celiac disease, inflammatory bowel disease etc. Congenital lactose intolerance is caused by genetic factors. The falling prices of lactose free foods due to rising scalability and larger sales will also stimulate the market. The non-serious nature of the symptoms of lactose intolerance is a major constraint on the market.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3868

Lactose Intolerance Treatment Market is expected to reach $ 9.4 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 7.2 % during forecast period.

The global lactose intolerance treatment market is segmented on the basis of type, treatment and end users. Based on type, the market has been segmented as primary, secondary, developmental and congenital. Based on the treatment, the market has been segmented as food supplements (dairy, milk substitutes (soy, rice, coconut, almond, others), cereals and breads, fats, others), enzymatic lactase supplements, and others. Based on the end users, the market has been segmented as hospitals and clinics, home use, and others.

Key Players

Johnson & Johnson Inc.,
National Enzyme Company,
Vetbiochem India Private Limited,
Scimera Partners,
Ganeden Biotech,
Daiya Foods Inc.,
Arla Foods,
McNeil Nutritionals,
Oberland-Milchverwertung (OMIRA),
Parmalat, Valio and others.

Market Segmentation

The lactose intolerance treatment market is segmented on the basis of treatment, type, region and end users. On the basis of type, the lactose intolerance treatment market has been segmented into secondary, primary, developmental and congenital. The treatment basis of segmentation of the market has been segmented into food supplements such as milk substitutes (soy, coconut, rice, almond among others), cereals and breads, dairy, fats, and others, enzymatic lactase supplements, and others. The end user segment of the market comprises of home use, hospitals and clinics, and others. The regions that are a share of the global lactose intolerance treatment market are the Middle East, Africa, Europe, North America, and the Asia Pacific.

Latest Industry News

Start-up Perfect Day is collaborating with Archer Daniels Midland to crease lactose-free whey which is plant-based.

Regional Analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global lactose intolerance treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.

Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/lactose-intolerance-treatment-market-3868

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Intracranial Hemorrhage Diagnosis and Treatment Market Segmentation Detailed Study with Forecast Up To 2019

Market Scenario:

The Global Intracranial Haemorrhage Treatment Market is chiefly driven by factors such as rising cases of trauma, accidents, age related brain disorders, cancer etc. The critical market constraints is the invasive nature of most intra-cranial pressure monitors.

Bleeding or haemorrhages loss of blood from the circulatory system which may be internal or external due to variety of conditions such as trauma, tissue damage due to surgery, accidents, cuts etc. Generally loss of 10–15% of the total blood volume does not cause serious mental problems and can be tolerated by the body. Intracranial haemorrhaging is bleeding in the brain due to trauma or medical conditions such as cancer, tumour etc.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3687

Considering all these factors the market for intracranial hemorrhage diagnosis and treatment is expected to reach $ 1.9 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 6.1 % during 2017-2023.

Key players:

Key players profiled in the report are Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Vittamed, Sophysa Ltd., Orsan Medical Technologies, and Spiegelberg GmbH, Johnson & Johnson, Sophysa Ltd, HaiWeiKang, Head Sense Medical, InfraScan, Inc., Integra Life Sciences Corporation and others.

Segmentation:

The global intracranial hemorrhage diagnosis and treatment market is segmented on the basis of devices and types. Based on the devices, the market has been segmented as invasive and non-invasive. The invasive segment is sub-segmented into ventricular drainage pressure monitors, lumbar drainage pressure monitors, micro-transducer pressure monitors. The non-invasive segment is sub-segmented into tissue resonance analysis (TRA) and Trans Cranial Doppler (TCD). Based on the types, the market has been segmented as intracranial hemorrhage treatment, cerebral hemorrhage, subarachnoid hemorrhage, postpartum hemorrhage, pulmonary hemorrhage, and other. Based on the drugs, the market has been segmented as anti-hypertensive, coagulants, and others. Based on the surgeries, the market has been segmented as decompression surgery, craniotomy with open surgery, simple aspiration, endoscopic evacuation, stereotactic aspiration, and clipping or coiling procedures.

Regional analysis:

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and rising awareness. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.

Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/intracranial-hemorrhage-diagnosis-and-treatment-market-3687

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Esophageal Cancer Market 2019 Market Challenge, Driver, Trends & Forecast to 2023

Esophageal Cancer Market Scenario:

Cancer is one of the leading causes of death worldwide and is expected to witness the expansion of patient population in the years to come. One of the types of cancer that affect the food pipe connecting the mouth and stomach is the esophageal cancer which is majorly prevalent among the older adults belonging to 55 years and above age group.

Market Research Future (MRFR) has found out that the global esophageal cancer market is projected to grow at a compound annual rate of 8.7% during the forecast period 2017 to 2023. It is underlined in the report that the market is anticipated to scale a decent valuation of USD 1000.1 Mn towards the close of 2023.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3280

The rising burden of cancer has paved the way for innovation in the market. It is one of the prime areas of research in the medical field. With the increasing number of drug patent applications in conjunction with the rising count of clinical trials, the esophageal cancer market is expected to witness a boom over the next couple of years. Key players are anticipated to exponentially invest in the development of more effective treatments which is forecasted to aid the proliferation of the esophageal market in the foreseeable future.

Addiction to tobacco, betel nuts, etc. is the key factor responsible for triggering esophageal cancer. Increasing shift towards a sedentary lifestyle has led to an increase in addiction problems among the masses. This, in turn, is expected to catalyze the growth of patient population. The future trajectory of the esophageal market is likely to remain highly lucrative over the next couple of years.

People are getting increasingly aware of the availability of treatments which is poised to aid market expansion. The support extended by governments in conjunction with the early detection of the disease has unleashed massive opportunities for the market players. It is anticipated to augment the esophageal cancer market in the long run.

Segmentation:

The global esophageal cancer market is segmented on the basis of type. Based on the type, the market has been segmented as esophageal squamous-cell carcinoma, esophageal adenocarcinoma and others. Based on the phases, the market has been segmented as phase I, phases II and phases III. Based on the treatment, the market has been segmented as surgery, chemotherapy and radiotherapy and other.

Intended Audience

Global Esophageal cancer solutions providers, manufacturers & suppliers
Research and development (R&D) companies
Market research and consulting service providers
Academic institutes and universities

Regional Analysis

The market of esophageal cancer is much higher in the Americas region attribute to high rate of tobacco, alcohol, very hot drinks, poor diet, and chewing betel nut. According to report published by American Cancer Society, in 2018, it is estimated that around 17,290 new cases of esophageal cancer diagnosed in Americas which include 13,480 of men and 3,810 of women and around 15,850 will be die. Additionally, In the United States, up to 200,000 people die each year from smoking-related illnesses that leads to incidence of esophageal cancer in this region. The government have more focus towards research and development for introducing the best treatment for their population.

Asia Pacific region are considering the growing market, owing to presence of huge population suffering with esophageal cancer. Whereas country like India and china are considering fastest growing region due to the high rate of tobacco and alcohol consumption which leads the incidence of esophageal cancer, additionally they are open to adopt new technology, and best treatment option from developed countries in order to improve the quality of life for their citizen. Whereas, the Middle East and Africa have low market due to his incapability of investment, Moreover, developing countries are still focusing on new drugs for the treatment of esophageal cancer, this gap between the developed and developing countries will present significant growth opportunity for the esophageal cancer market players in the coming years.

Europe is also consider huge market for esophageal cancer players, owing to present of huge population affected with disease. According to Cancer Research U.K, in 2014, esophageal cancer holds 2 percent of total cancer cases in United Kingdom. Government are more focusing to educate their public in order to minimize the patient’s population by educating them about the side effect of tobacco, alcohol etc.

Key players of Global Esophageal cancer Market:

Amgen
Eli Lilly and Company,
Hoffmann-La Roche,
Bristol-Myers Squibb Company,
Boehringer Ingelheim GmbH,
Bristol-Myers Squibb,
GlaxoSmithKline Plc.,
Novartis AG,
Johnson & Johnson,
Gilead Sciences,
Merck & Co.

Browse Premium Research Report with List of Tables and Figures @ https://www.marketresearchfuture.com/reports/esophageal-cancer-market-3280

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Bioinformatics Market Segmentation Detailed Study with Forecast Up To 2019

The Global Bioinformatics Market is expected to exhibit a CAGR of 19.8% over the forecast period from 2016 to 2022, according to a new research report from Market Research Future (MRFR). The global bioinformatics market is mainly driven by the growing demand in developing countries in enhancing their healthcare sector and making advanced healthcare modalities available to patients.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2265

The growing demand for electronic healthcare data storage is likely to be a major driver for the global bioinformatics market. The reliance on manual and paper-based documentation of healthcare procedures has resulted in unmanageable volumes of healthcare information, which can make it difficult to locate individual patients and their medical history. Electronic healthcare records, which are but the first step of the bioinformatics market, have already become widely popular in developed countries due to the benefits they present in terms of consistent data storage over the long term and ease in acquiring specific details at any given time. The growing demand for e-prescriptions and online pharmacies is likely to further the cause of the bioinformatics market over the forecast period, as strong bioinformatics networks are needed to operate and manage e-prescriptions and the related documentation.

The growing demand for strong data storage facilities in medical research is also likely to be a major driver for the global bioinformatics market. Bioinformatics plays a key role in genetic studies, in which it helps track details regarding multiple genes and their multifarious associations with the indicators being studied in the respective trial. The growing dependence on genetic studies in cancer research is likely to be a major driver for the global bioinformatics market over the forecast period, as cancer research has received strong government backing across the world. Other medical research applications are also likely to make use of bioinformatics systems on a large scale in the coming years, leading to steady growth of the global bioinformatics market over the forecast period.

Study Objectives of Bioinformatics Market:

To provide detail analysis of the market structure along with forecast for the next 7 years about various segments and sub-segments of the global bioinformatics market.
To provide insights about factors affecting the market growth.
To analyze the market based on price analysis, supply chain analysis, Porters Five Force analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future growth prospective.
To provide country level analysis of the market for segments by drug application, by technology, by sector and services and its sub-segments.
To provide overview about key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing a competitive landscape of the market.
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Bioinformatics market.

Intended Audience

Bioinformatics service providers
Bioinformatics manufacturers
Research and development (R&D) companies
Government research laboratories
Government and independent regulatory authorities

Segmentation:

The global bioinformatics market is segmented on the basis of application, service, sector, and region in the MRFR report in order to provide a comprehensive coverage of all important factors related to the market’s growth prospects over the forecast period.

The bioinformatics market has been segmented on the basis of application into genomics, chemoinformatics, drug design, transcriptomics, molecular phylogenetics, proteomics, metabolomics, DNA sequences, and others. Increasing interest in genetic studies is likely to be a major driver for the global bioinformatics market over the forecast period.

On the basis of services and technology, the global bioinformatics market is segmented into data warehousing, sequence analysis, sequence manipulation, and others.

Key Players for Bioinformatics Market:

Agilent Technologies,
Illumina, Inc.,
QIAGEN N. V, and Thermo Fisher Scientific Inc.,
Dassault Systèmes,
QIAGEN and others.

Regional Analysis:

The global bioinformatics market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The global bioinformatics market is dominated by the Americas and Europe in terms of region due to the presence of strong telecommunications infrastructure in these regions to support advanced bioinformatics processes. The presence of a strong wireless internet and other telecommunication features is crucial for a bioinformatics system to function productively. This has actually been one of the key factors that has held back the bioinformatics market in underdeveloped regions.

In April 2019, researchers from UCLA announced a plan to develop a system that would allow scientists in developing countries to use cloud computing and big data analytics to accelerate the development of the bioinformatics field in their own countries. Efforts such as these are the result of the growing awareness of the disparity in terms of telecommunications infrastructure between developed and developing countries.

Asia Pacific is likely to exhibit the fastest growth over the forecast period due to the increasing efforts from governments in the region to incorporate powerful bioinformatics programs into the day-to-day functioning of their country’s healthcare sector.

Browse Complete 80 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/bioinformatics-market-2265

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Wound Closure Device Market Segmentation Detailed Study with Forecast Up To 2019

Market Scenario:
Global Wound Closure Device Market has been growing rapidly and is expected to grow further. Effective and instant healers and also, these are useful when wound healing is difficult with traditional methods producing high risk of infection, these wound closer option are quick, easy to apply and remove and also had minimum cost associated with them has increased The Global Wound Closure Device Market globally. Other factors which restraint the growth of global wound closer market includes avoidance in highly visible areas such as face to minimize scarring, medical glues used as a wound closer device has less efficiency and is normally only one fifth as effective as sutures decreasing its demand for many procedures and injuries.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2001
The global wound closure device market is expected to grow during the forecast period (2018 to 2023) at a CAGR ~6.9%.
Moreover, advancement in technology, decrease in a number of surgical site infections and attempts to reduce hospital stays for reducing surgical expenditure is contributing to the growth of the market. According to a survey conducted by the American Professional Wound Care Association (2017), chronic nonhealing wounds impact nearly 15% of Medicare beneficiaries (8.2 million). The estimated spending for primary wound diagnosis is USD 28 billion per year and the cost for secondary wound diagnosis is estimated to be USD 31.7 billion.
The risk associated with infectious wounds, side effects of wound closure devices, and unfavorable reimbursement policies may hamper the growth of the market during the assessment period.
Key Players

3M,
Abbott Laboratories,
Braun Melsungen AG,
Ethicon Inc.,
,
Smith & Nephew,
Baxter International,
BSN medical Inc.,
Derma Sciences,
Kinetic Concepts,
ConvaTec,
DACH Medical Group,
Arthrex GmbH,
Gecko Biomedical,
Integra LifeScience,
CP Medical.

Segmentation
The global wound closure device market has been segmented based on device, application, type of wound, and end-user.
On the basis of device, the market has been classified into adhesives, staples, sutures, and mechanical wound closure devices. Adhesives are furthers classified into fibrin tissue adhesives and cyanoacrylates. The sutures segment has been further divided into absorbable, non- absorbable, braided, and monofilament.
On the basis of application, the market has been classified into burns, ulcers, surgical wounds, pressure ulcers, diabetic ulcers, and arterial ulcers. On the basis of type, the surgical wounds segment has been sub-segmented into chronic wounds, acute wounds, and others.
The market, by end-user, has been segmented into hospitals, community healthcare service providers, ambulatory surgical centers, and home care.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The wound closure device market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European wound closure device market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The wound closure device market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The wound closure device market in the Middle East and Africa has been segmented into the Middle East and Africa.
Regional Market Summary
The Americas is likely to hold the majority of the global wound closure device market owing to increase in the number of surgical procedures, increasing injuries related to accidents, sports and adventure, aging population, the presence of a well-established healthcare system, and adoption and awareness of the wound closure technology. According to the American Association for the Surgery of Trauma, injury accounts for over 150,000 deaths and over 3 million non-fatal injuries are reported per year in the US.
The European market is expected to be the second-largest wound closure device market after the Americas. The market growth in this region can be attributed to an increase in aged population and rising occurrence of sports injuries and accidents. Moreover, the growing number of road accidents in the European region are contributing to the growth of the market in this region. According to data published by the European Commission in 2018, more than 135,000 people suffered serious injury from road accidents.
Asia-Pacific is expected to be the fastest-growing wound closure device market during the forecast period owing to the significant increase in aged population, increasing prevalence of chronic diseases such as diabetes leading to the increasing cases of diabetic foot ulcer. According to WHO, there are more than 96 million diabetics patients in the Asia-Pacific region.
The market in the Middle East and Africa is expected to account for the smallest share of the global wound closure device market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Browse Complete 90 Pages Premium Research Report Enabled with 92 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/wound-closure-device-market-2001
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Cardiovascular Needle Market 2019 Market Challenge, Driver, Trends & Forecast to 2023

Market Insights:

According to the International Diabetes Federation in 2016, it was estimated that 420 million adult population had diabetes, which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040. Furthermore, increasing prevalence of population suffering from cardiovascular diseases, diabetes, and obesity driving the growth of the cardiovascular needles market globally.

The global cardiovascular needles market is growing rapidly owing to its application in various fields such as open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1234

According to the World Health Organization (WHO) in 2015, around 1.6 million deaths were directly caused by diabetes and in 2014, 8.5% of adults aged 18 years and older had diabetes. Thus, rising prevalence of chronic diseases is majorly driving the global cardiovascular market.

According to the World Health Organization (WHO), in 2015, around 17.7 million people died from cardiovascular diseases, which represents 31% of all global deaths. Of these deaths, around 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.

Various factors are adding fuel to the growth of the global cardiovascular needle market, such as unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of diabetes; more than 60% of the global population smokes, this has increased the risk of diabetes and contributed to the growth of the market.

Moreover, advancing technology in the medical devices is adding fuel to the growth of the market. Furthermore, increasing government support in the developing countries drive the market growth.

However, increasing use of surgical staples instead of needles and suture can deter the demand for cardiovascular needles.

The global cardiovascular needle market is expected to grow at a CAGR of 7.2% during the forecast period 2017-2023.

Key Players

Some of the key the players in the market are Becton, Dickinson, and Company (US), B. Braun Melsungen AG (Germany), Sheffield Ltd. (UK), CP Medical, Inc. (the US), Ethicon Inc. (US), KLS Martin Group (US), Sklar Surgical Instruments (US), Rumex International Corporation Ltd. (US), Scanlan International Inc. (US), Teleflex Incorporated (US), Medline Industries, Inc. (US), Surgins surgical Ltd. (UK), Surtex Instruments Ltd. (UK), Cardivon Surgical Inc. (China), Symmetry Surgical Inc. (US), Delacroix-Chevalier (France), Wexler Surgical (US), Quality Needles Pvt. Ltd. (India), FSSB surgical needles GmbH (Germany)

Segmentations

The global cardiovascular needle market is segmented on the basis of types, by application, by usage, and by the end user.

On the basis of the type, it is segmented into round bodied needles and cutting needles. Furthermore, round-bodied needles segmented into taper point needles and blunt point needles. Also, cutting needles segmented into conventional cutting needles and reverse cutting needles.

On the basis of the application, it is segmented into open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.

On the basis of the usage, it is segmented into single use and multiple uses.

On the basis of the end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others.

Regional Analysis

The Americas dominate the global cardiovascular needle market owing to the rising prevalence of diabetes, obesity, and cardiovascular diseases. Furthermore increasing government support for research & development have fuelled the growth of the market in this region. According to the American Heart Association, in 2017, cardiovascular disease listed as the underlying cause of death which is likely to account for nearly 801,000 deaths in the US by the end of this year. It further estimated that about 2,200 Americans die of cardiovascular disease each day.

Europe holds the second position in the global cardiovascular needle market owing to the presence of major players. Although companies within this region are also involved in export to the developing countries which leads the market of Europe.

The Asia Pacific is the fastest growing Cardiovascular Needle market owing to the high presence of a patient with cardiovascular disease. Furthermore, the government of this region is looking forward to better the quality of needles, which increases the demand for cardiovascular needle market in this region.

On the other hand, in the Middle East and Africa hold the least market due to low research and development activities and poor healthcare infrastructure.

Browse 110 Pages Premium Research Report with Tables and Figures @ https://www.marketresearchfuture.com/reports/cardiovascular-needle-market-1234

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Amblyopia Market Expected to Grow at High Cagr during Forecast Period 2019 – 2023

Amblyopia is an eye disorder which leads to decreased vision in one or both the eyes due to suppressed input from the brain. The most common cause of amblyopia is a refractive error in one or both eyes, or it might even occur due to muscle imbalance. The other cause of amblyopia is if the infant is born with a cataract, which causes cloudy images. There are four types of amblyopia, namely, Strabismus Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, and Reverse Amblyopia. The global prevalence rate of Amblyopia is 2 to 3% of the infant population. Amblyopia market is driven by growing incidence of ophthalmological disorders such as cataracts, macular degeneration, glaucoma, and refractive errors. According to reports published by the United Kingdom Statistics Authority, in 2015, around 15,900 people were registered as visually impaired. Moreover, according to the Journal of Ophthalmology, as of 2014 there were around 28 million visually impaired people in the European region. With the increasing prevalence, there is increasing in the advancement of treatment and hence influencing the growth of the market.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4353

Amblyopia, commonly known as lazy eye, is a vision impairment disorder, in which one or both the eyes have reduced or no vision. Amblyopia can begin during infancy or early childhood. Amblyopia requires detection and diagnosis early in childhood, which otherwise can lead to blindness during later life. On the basis of type, amblyopia can be divided into, Strabismic amblyopia, Refractive amblyopia, Deprivation amblyopia, and Reverse Amblyopia.

Global amblyopia market is expected to grow at a CAGR of 3.80% during the forecast period 2017-2023.

Key Players

Amblyoptica (Holding) Pty Ltd,
Amblyotech, Inc,
Good-Lite Co,
Vivid Vision, Inc.,
Cooper Vision,
Johnson & Johnson,
Novartis AG.,
Carl Zeiss AG,
HOYA Corporation,
Krafty Eye Patches¸
Fresnel Prism and Lens Co.,
Hilco Vision,
McKesson Corporation

Segmentation

The global amblyopia market is segmented on the basis of type, diagnosis, treatment, and end-user.

On the basis the type, it is segmented into strabismus amblyopia, refractive amblyopia, deprivation amblyopia, reverse amblyopia, and other.

On the basis of the diagnosis, it is segmented into visual acuity tests, photo screening, Bruckner test and others.

On the basis of the treatment, it is segmented into eye patches, atropine drops, glasses, video game and others.

On the basis of the end-user, it is segmented into hospitals & pharmacies, ophthalmic clinics, and others.

Regional analysis

The global amblyopia market, on the basis of region, is divided into the Americas, Europe, Asia Pacific and the Middle East & Africa. The Americas accounted for the largest market share of 37.9% in 2016 for global amblyopia market. This large share is majorly attributed due to the increasing prevalence of ophthalmological disorders, the presence of major manufacturers, increasing technological advancement and high healthcare expenditure. Europe accounts for the second largest market share, whereas Asia Pacific is expected to grow at the fastest rate with 4.35% CAGR for the forecast period. With lots of opportunity and continuously growing economies, the presence of huge patient population, rapid development in technology and presence of a huge opportunity for the development the region is expected to be the fastest growing region. The Middle East & Africa is growing at a slow pace, and the low income accounted for the least market share in 2016 but is expected to grow in the coming future.

Browse Premium Research Report with Tables and Figures @ https://www.marketresearchfuture.com/reports/amblyopia-market-4353

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com